Planning

DHSC: Naloxone & Alternative Opioid Antagonists - Buffer Stock Storage & Management

  • DHSC, London

UK2: Preliminary market engagement notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2025/S 000-016810

Procurement identifier (OCID): ocds-h6vhtk-0506ad

Published 24 April 2025, 9:34am

Last edited 24 April 2025, 2:46pm

Show all versions Hide all versions


Changes to notice

This notice has been edited. The previous version is still available.

updated link

Scope

Reference

C355337

Description

DHSC is conducting market engagement to understand more about the companies and services in the UK that can, or that are seeking to produce, distribute, supply and store different formulations of take-home naloxone that can reverse the effect of an opioid overdose. In particular, we are looking to understand how these suppliers and manufacturers could potentially meet the future of needs of a UK Buffer Stock of Naloxone. This is not a call for competition, but an opportunity to gather feedback via a questionnaire to better understand market capabilities, and encourage supplier engagement. Interested parties can access the relevant documents via the Atamis system at https://health-family.force.com/s/Welcome using the contract reference, you may also submit the completed questionnaire through Atamis but must be registered on the system to do so. Alternatively, submit questionnaires to ccsinbox@dhsc.gov.uk

Total value (estimated)

  • £1,900,000 excluding VAT
  • £2,280,000 including VAT

Above the relevant threshold

Contract dates (estimated)

  • 1 October 2025 to 31 August 2026
  • Possible extension to 31 August 2028
  • 2 years, 11 months

Main procurement category

Goods

CPV classifications

  • 33600000 - Pharmaceutical products
  • 33670000 - Medicinal products for the respiratory system
  • 33693300 - Addiction treatment

Contract locations

  • UK - United Kingdom

Engagement

Engagement deadline

9 May 2025

Engagement process description

DHSC is conducting market engagement to understand more about the companies and services in the UK that can, or that are seeking to produce, distribute, supply and store different formulations of take-home naloxone that can reverse the effect of an opioid overdose. In particular, we are looking to understand how these suppliers and manufacturers could potentially meet the future of needs of a UK Buffer Stock of Naloxone. This is not a call for competition, but an opportunity to gather feedback via a questionnaire to better understand market capabilities, and encourage supplier engagement. Interested parties can access the relevant documents via the Atamis system at https://health-family.force.com/s/Welcome using the contract reference, you may also submit the completed questionnaire through Atamis but must be registered on the system to do so. Alternatively, submit questionnaires to ccsinbox@dhsc.gov.uk


Submission

Publication date of tender notice (estimated)

23 May 2025


Contracting authority

DHSC, London

  • Public Procurement Organisation Number: PMQG-9965-CHZR

39 Victoria Street

London

SW1H 0EU

United Kingdom

Region: UKI32 - Westminster

Organisation type: Public authority - central government